Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Rocket Lab slides as broader growth-stock weakness appears to outweigh recent operational milestones

None

Rocket Lab Corporation (RKLB) is down 4.1% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied more to broad selling in higher-growth technology and space stocks than to a fresh company-specific setback on November 17, 2026. Rocket Lab had recently posted strong quarterly revenue and backlog growth and completed its 100th Electron launch, so today’s decline looks like continued risk-off trading while investors also digest the earlier slip of Neutron’s debut into 2027.

Details:

  • U.S. equities were under pressure again on Tuesday, November 17, 2026, with technology shares remaining weak, creating a tougher backdrop for momentum-driven names.
  • Rocket Lab recently reported record third-quarter 2026 revenue, positive GAAP operating cash flow, and major backlog expansion, which suggests today’s drop was not obviously driven by a weak operating update.
  • The company also announced more than $515 million in Neutron launch deals during the quarter, but investors are still balancing that against the previously disclosed schedule shift for Neutron’s first launch into 2027.
  • Rocket Lab completed its 100th Electron launch over the weekend, so the stock may be giving back some gains as traders rotate away from space and other high-beta growth names.
  • Sources:

    Rocket Lab Investor Relations, SEC, AP News, Yahoo Finance

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $RKLB Insider Trading Activity

    RKLB Insider Trades

    $RKLB insiders have traded $RKLB stock on the open market 106 times in the past 6 months. Of those trades, 0 have been purchases and 106 have been sales.

    Here’s a breakdown of recent trading of $RKLB stock by insiders over the last 6 months:

    • PETER BECK (CEO) has made 0 purchases and 24 sales selling 3,275,779 shares for an estimated $286,410,195.
    • ADAM C. SPICE (Chief Financial Officer) has made 0 purchases and 19 sales selling 492,892 shares for an estimated $35,721,031.
    • ARJUN KAMPANI (SVP & General Counsel) has made 0 purchases and 22 sales selling 224,260 shares for an estimated $28,199,913.
    • FRANK KLEIN (Chief Operations Officer) has made 0 purchases and 20 sales selling 162,500 shares for an estimated $17,312,632.
    • ALEXANDER R SLUSKY has made 0 purchases and 3 sales selling 100,000 shares for an estimated $13,908,092.
    • MARVIN BRADFORD CLEVENGER (President, Rocket Lab USA, Inc) has made 0 purchases and 10 sales selling 34,100 shares for an estimated $3,778,202.
    • NINA ARMAGNO has made 0 purchases and 5 sales selling 10,926 shares for an estimated $576,646.
    • AGOSTINO RICUPATI (VP Corp Controller & CAO) has made 0 purchases and 3 sales selling 669 shares for an estimated $46,581.

    To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

    $RKLB Hedge Fund Activity

    We have seen 701 institutional investors add shares of $RKLB stock to their portfolio, and 516 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

    $RKLB Government Contracts

    We have seen $161,010,824 of award payments to $RKLB over the last year.

    Here are some of the awards which we have have seen pay out the most over the last year:

    To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

    $RKLB Analyst Ratings

    Wall Street analysts have issued reports on $RKLB in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

    Here are some recent analyst ratings:

    • Morgan Stanley issued a "Overweight" rating on 11/11/2026
    • Needham issued a "Buy" rating on 11/11/2026
    • Barclays issued a "Overweight" rating on 11/10/2026
    • Keybanc issued a "Overweight" rating on 11/10/2026
    • Cantor Fitzgerald issued a "Overweight" rating on 11/10/2026
    • Citizens issued a "Market Outperform" rating on 10/16/2026
    • TD Cowen issued a "Buy" rating on 10/15/2026

    To track analyst ratings and price targets for $RKLB, check out Quiver Quantitative's $RKLB forecast page.

    $RKLB Price Targets

    Multiple analysts have issued price targets for $RKLB recently. We have seen 15 analysts offer price targets for $RKLB in the last 6 months, with a median target of $103.0.

    Here are some recent targets:

    • Kristine Liwag from Morgan Stanley set a target price of $103.0 on 11/11/2026
    • Ryan Koontz from Needham set a target price of $100.0 on 11/11/2026
    • Alexander Potter from Piper Sandler set a target price of $58.0 on 11/10/2026
    • Anthony Valentini from Barclays set a target price of $82.0 on 11/10/2026
    • Michael Leshock from Keybanc set a target price of $100.0 on 11/10/2026
    • Andres Sheppard from Cantor Fitzgerald set a target price of $111.0 on 11/10/2026
    • Trevor Walsh from Citizens set a target price of $90.0 on 10/16/2026

    This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

    Add Quiver Quantitative to your preferred sources on Google Google News Logo

    Suggested Articles